The state of the fight:Multiple wealthy countries outlined imminent booster dose plans, spurning a WHO plea for patience.
Novavax pushed back its timeline for seeking U.S. FDA authorization for its vaccine and said the U.S. had paused funding for the shot’s production.
The African Vaccine Acquisition Trust announced its first shipments of doses.
Approved or authorized vaccines
J&J’s shot offers up to 96.2% protection against death,…